Sipoglitazar
Sipoglitazar is a selective PPARγ agonist investigated for the treatment of type 2 diabetes. It has been utilized in both in vitro assays and in vivo animal models to study insulin sensitization, glucose homeostasis, and metabolic syndrome pathways.
Product Specifications
CAS Number
342026-92-0
Field of Research
Metabolism Research, Molecular Biology
Smiles
C (CC (O) =O) C=1C (OCC) =NN (CC2=CC=C (OCC=3N=C (SC3) C4=CC=CC=C4) C=C2) C1
Molecular Formula
C25H25N3O4S
Molecular Weight
463.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP64748_P050 100 µL
TXNRD3 Antibody - N-terminal region (ARP64748_P050)
Sign In for Pricing
View Details 
K0026602 1.0 µg DNA
ACAP1 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
H-5516.0001 1.0mg
(Tyr0)-Prepro-Atrial Natriuretic Factor (104-123) (human)
Sign In for Pricing
View Details